Home > Insider Trading > Filing (0001014108-15-000228)

Filing Details

Accession Number:: 0001014108-15-000228
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2015-08-25 11:37:41
Reporting Period:: 2015-06-09

Filing Date:: 2015-08-25
Accepted Time:: 2015-08-25 11:37:41
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1084597	Xzeres Corp.	XPWR	Engines & Turbines (3510)	742329327

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1598555	Paul Debruce	411 Nichols Road Suite 217 Kansas City MO 64112		No	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Series B Participating Preferred, Par Value $.001 Per Share	Acquisiton	2015-06-09	1,190	$2,000.00	1,190	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock, Par Value $.001 Per Share	15,219,672	Direct

Reported Derivative Holdings

Show Other Fields >>

Sec. Name	Sec. Type	Price	Date	Expiration Date	Amount	Remaning Holdings	Nature of Ownership
Common Stock	Warrants (right to buy)	$0.23	2013-07-31	2017-07-31	976,658	976,658	Direct
Common Stock	Warrants (right to buy)	$0.25	2013-10-01	2017-10-01	687,047	687,047	Direct
Common Stock	Warrants (right to buy)	$0.31	2013-12-16	2016-12-16	2,794,256	2,794,256	Direct
Common Stock	Warrants (right to buy)	$0.30	2014-04-23	2018-04-23	1,144,984	1,144,984	Direct

Expiration Date	Amount	Remaning Holdings	Nature of Ownership
2017-07-31	976,658	976,658	Direct
2017-10-01	687,047	687,047	Direct
2016-12-16	2,794,256	2,794,256	Direct
2018-04-23	1,144,984	1,144,984	Direct

Footnotes

The number of shares to which these warrants relate, as well as their respective exercise prices, are subject to antidilution adjustment provisions.
This warrant is exercisable for such number of shares as equals 1.03459% of the fully diluted outstanding shares of Common Stock upon payment of an aggregate exercise price of $228,951, and previously was reported as relating to 829,246 shares. After giving effect to the warrant's antidilution provisions, as of April 3, 2015, the warrant is exercisable for a total of 976,658 shares of Common Stock upon payment of an aggregate exercise price of $228,951 ($0.2344 per share), subject to further adjustment under the warrant's antidilution provisions.
This warrant is exercisable for such number of shares as equals 0.7278% of the fully diluted outstanding shares of Common Stock upon payment of an aggregate exercise price of $174,417, and previously was reported as relating to 583,347 shares. After giving effect to the warrant's antidilution provisions, as of April 3, 2015, the warrant is exercisable for a total of 687,047 shares of Common Stock upon payment of an aggregate exercise price of $174,417 ($0.2539 per share), subject to further adjustment under the warrant's antidilution provisions.
This warrant is exercisable for such number of shares as equals 2.96% of the fully diluted outstanding shares of Common Stock upon payment of an aggregate exercise price of $855,555, and previously was reported as relating to 2,372,503 shares. After giving effect to the warrant's antidilution provisions, as of April 3, 2015, the warrant is exercisable for a total of 2,794,256 shares of Common Stock upon payment of an aggregate exercise price of $855,555 ($0.3062 per share), subject to further adjustment under the warrant's antidilution provisions.
This warrant is exercisable for such number of shares as equals 1.2129% of the fully diluted outstanding shares of Common Stock upon payment of an aggregate exercise price of $339,206, and previously was reported as relating to 972,165 shares. After giving effect to the warrant's antidilution provisions, as of April 3, 2015, the warrant is exercisable for a total of 1,144,984 shares of Common Stock upon payment of an aggregate exercise price of $339,206 ($0.2963 per share), subject to further adjustment under the warrant's antidilution provisions.